USFDA inspection at Piramal Pharma Ltd's Bethlehem facility

The US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma Limited's Bethlehem facility from 18th September 2023 to 27th September 2023.

On conclusion of the inspection, a Form-483 was issued with 2 observations. Both observations relate to system improvement only, and none are related to data integrity. The Company is preparing a detailed response to said observations, which will be submitted to the US FDA within stipulated timelines.

The Company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all observations.

Shares of Piramal Pharma Limited was last trading in BSE at Rs. 97.50 as compared to the previous close of Rs. 96.85. The total number of shares traded during the day was 258617 in over 3670 trades.

The stock hit an intraday high of Rs. 97.90 and intraday low of 95.75. The net turnover during the day was Rs. 25100312.00.

Source : Equity Bulls

Keywords

PiramalPharma PPLPHARMA INE0DK501011 Pharmaceuticals USFDA GMPInspection BethlehemFacility Form483 2Observations